Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

P3 Health Partners (PIIIW) Revenue (2020 - 2025)

P3 Health Partners' Revenue history spans 6 years, with the latest figure at $384.8 million for Q4 2025.

  • For Q4 2025, Revenue rose 3.81% year-over-year to $384.8 million; the TTM value through Dec 2025 reached $1.5 billion, down 2.76%, while the annual FY2025 figure was $1.5 billion, 2.76% down from the prior year.
  • Revenue reached $384.8 million in Q4 2025 per PIIIW's latest filing, up from $345.3 million in the prior quarter.
  • In the past five years, Revenue ranged from a high of $388.5 million in Q1 2024 to a low of $1.5 million in Q1 2021.
  • Average Revenue over 5 years is $285.2 million, with a median of $315.6 million recorded in 2023.
  • Peak YoY movement for Revenue: surged 17776.76% in 2022, then decreased 6.16% in 2025.
  • A 5-year view of Revenue shows it stood at $126.5 million in 2021, then soared by 104.07% to $258.2 million in 2022, then skyrocketed by 34.33% to $346.9 million in 2023, then rose by 6.87% to $370.7 million in 2024, then increased by 3.81% to $384.8 million in 2025.
  • Per Business Quant, the three most recent readings for PIIIW's Revenue are $384.8 million (Q4 2025), $345.3 million (Q3 2025), and $355.8 million (Q2 2025).